Radiumhemmet is a non-surgical cancer treatment and radiotherapy research institution in Solna, Sweden. Since 1938, it has been a division of what is now the Karolinska University Hospital.

During the past decade, Karolinska Hospital; Oncology - Radiumhemmet conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Karolinska Hospital; Oncology - Radiumhemmet" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Karolinska University Hospital" with 4 trials sponsored, "Dr Anders Ullén" with 2 trials sponsored, "Thomas Hatschek" with 2 trials sponsored and "Ass. Prof. Jan Nyman" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karolinska Hospital; Oncology - Radiumhemmet" #1 collaborator was "German Breast Group" with 2 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator and "Cyto Pulse Sciences, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Karolinska Hospital; Oncology - Radiumhemmet" are "Breast Cancer" (7 trials), "Bladder Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Renal Pelvis Cancer" (2 trials) and "Ureter Cancer" (2 trials). Many other conditions were trialed in "Karolinska Hospital; Oncology - Radiumhemmet" in a lesser frequency.

Most popular intervention types in "Karolinska Hospital; Oncology - Radiumhemmet" are "Drug" (18 trials), "Radiation" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (4 trials), "Atezolizumab" (3 trials), "Bevacizumab" (3 trials), "Vinflunine" (3 trials) and "Capecitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Karolinska Hospital; Oncology - Radiumhemmet" are 14 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Karolinska Hospital; Oncology - Radiumhemmet". 1 are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Karolinska Hospital; Oncology - Radiumhemmet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Karolinska Hospital; Oncology - Radiumhemmet, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".